TY - JOUR
T1 - An osteoconductive PLGA scaffold with bioactive β-TCP and anti-inflammatory Mg(OH)2 to improve
T2 - In vivo bone regeneration
AU - Go, Eun Jin
AU - Kang, Eun Young
AU - Lee, Seul Ki
AU - Park, Sookhyun
AU - Kim, Jae Hwa
AU - Park, Wooram
AU - Kim, Ik Hwan
AU - Choi, Bogyu
AU - Han, Dong Keun
N1 - Funding Information:
This work was supported by the Basic Science Research Program (2017R1A2B3011121) and Bio & Medical Technology Development Program (2018M3A9E2024579) through the National Research Foundation of Korea funded by the Ministry of Science and ICT (MSIT), a grant of the Korea Health Technology R&D Project (HI18C0089) through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, and Core Materials Technology Development Program (10048019) funded by Ministry of Trade, Industry and Energy (MOTIE), Republic of Korea.
Publisher Copyright:
© The Royal Society of Chemistry 2020.
PY - 2020/2/20
Y1 - 2020/2/20
N2 - Poly(lactic-co-glycolic acid) (PLGA) has been widely used as a biomaterial for pharmaceutical and medical applications. However, the decomposition products of PLGA are known to acidify the surrounding tissue of the implanted site, causing an inflammatory response. Previously, we developed PLGA/inorganic nanocomposites and optimized the amounts of inorganic compounds, β-tricalcium phosphate (β-TCP) and magnesium hydroxide [Mg(OH)2], in terms of osteogenesis of normal human osteoblasts and anti-inflammatory responses of preosteoclastic cells in vitro. In this study, the potential of the optimized PLGA/β-TCP/Mg(OH)2 nanocomposite (TCP/MH) to promote bone repair through osteoinductive, osteoconductive, and anti-inflammatory abilities was assessed using a bone defect in a rat humeral defect model. PLGA nanocomposites with or without inorganic compounds, PLGA, β-TCP, MH, and TCP/MH were prepared through one-step bulk modification using a twin-screw extruder. The resulting TCP/MH nanocomposite successfully enhanced the bone regeneration rate for allowing complete bone defect healing with significantly suppressed inflammatory responses. Taken together, the organic and inorganic bioactive nanocomposite developed in this study, TCP/MH, is a promising material in orthopedic implantation.
AB - Poly(lactic-co-glycolic acid) (PLGA) has been widely used as a biomaterial for pharmaceutical and medical applications. However, the decomposition products of PLGA are known to acidify the surrounding tissue of the implanted site, causing an inflammatory response. Previously, we developed PLGA/inorganic nanocomposites and optimized the amounts of inorganic compounds, β-tricalcium phosphate (β-TCP) and magnesium hydroxide [Mg(OH)2], in terms of osteogenesis of normal human osteoblasts and anti-inflammatory responses of preosteoclastic cells in vitro. In this study, the potential of the optimized PLGA/β-TCP/Mg(OH)2 nanocomposite (TCP/MH) to promote bone repair through osteoinductive, osteoconductive, and anti-inflammatory abilities was assessed using a bone defect in a rat humeral defect model. PLGA nanocomposites with or without inorganic compounds, PLGA, β-TCP, MH, and TCP/MH were prepared through one-step bulk modification using a twin-screw extruder. The resulting TCP/MH nanocomposite successfully enhanced the bone regeneration rate for allowing complete bone defect healing with significantly suppressed inflammatory responses. Taken together, the organic and inorganic bioactive nanocomposite developed in this study, TCP/MH, is a promising material in orthopedic implantation.
UR - http://www.scopus.com/inward/record.url?scp=85079017905&partnerID=8YFLogxK
U2 - 10.1039/c9bm01864f
DO - 10.1039/c9bm01864f
M3 - Article
C2 - 31833498
AN - SCOPUS:85079017905
SN - 2047-4830
VL - 8
SP - 937
EP - 948
JO - Biomaterials Science
JF - Biomaterials Science
IS - 3
ER -